Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multi-Center, Non-Interventional Study, on the Efficacy of Dual and Triple Therapies Based on Pegylated Interferon Alfa-2a for the Treatment of Chronic Hepatitis C Patients

NCT01604291 is registered in ClinicalTrials.gov with Hoffmann-La Roche as lead sponsor.

NCT NCT01604291
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01604291 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multi-Center, Non-Interventional Study, on the Efficacy of Dual and Triple Therapies Based on Pegylated Interferon Alfa-2a for the Treatment of Chronic Hepatitis C Patients
Lead sponsor
Hoffmann-La Roche
Phase
Observational
Overall status
Completed
Start date
May 28, 2012
Completion date
February 10, 2016
Enrollment
991 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis c, chronic